Trial · NCT04201262
Participant flow16
How many started, completed or left each group, period by period.
1 to 16 of 16
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Primary Treatment Period | STARTED | Ravulizumab | 58 | |
| Primary Treatment Period | STARTED | Placebo (ECU-NMO-301) | 47 | |
| Primary Treatment Period | Received at Least 1 Dose of Study Drug | Ravulizumab | 58 | |
| Primary Treatment Period | Received at Least 1 Dose of Study Drug | Placebo (ECU-NMO-301) | 47 | |
| Primary Treatment Period | COMPLETED | Ravulizumab | 56 | |
| Primary Treatment Period | COMPLETED | Placebo (ECU-NMO-301) | 44 | |
| Primary Treatment Period | NOT COMPLETED | Ravulizumab | 2 | |
| Primary Treatment Period | NOT COMPLETED | Placebo (ECU-NMO-301) | 3 | |
| Long-term Extension Period | STARTED | Ravulizumab | 56 | |
| Long-term Extension Period | STARTED | Placebo (ECU-NMO-301) | 0 | |
| Long-term Extension Period | Received at Least 1 Dose of Study Drug | Ravulizumab | 56 | |
| Long-term Extension Period | Received at Least 1 Dose of Study Drug | Placebo (ECU-NMO-301) | 0 | |
| Long-term Extension Period | COMPLETED | Ravulizumab | 55 | |
| Long-term Extension Period | COMPLETED | Placebo (ECU-NMO-301) | 0 | |
| Long-term Extension Period | NOT COMPLETED | Ravulizumab | 1 | |
| Long-term Extension Period | NOT COMPLETED | Placebo (ECU-NMO-301) | 0 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04201262/flow